Fecal Microbiota Transplantation for Recurrent Clostridium difficile Infection Reduces Recurrent Urinary Tract Infection Frequency
Authors:
- 18 July 2017
- journal article
- research article
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 65 (10) , 1745-1747
Abstract
Broad-spectrum antibiotics for recurrent multidrug-resistant urinary tract infections (UTIs) disrupt the gut microbiome and promote antibiotic resistance. Fecal microbiota transplantation led to resolution of recurrent Clostridium difficile, significantly decreased recurrent UTI frequency, and improved antibiotic susceptibility profile of UTI-causing organisms.Keywords
This publication has 9 references indexed in Scilit:
- Understanding the mechanisms of faecal microbiota transplantationNature Reviews Gastroenterology & Hepatology, 2016
- Clearance of Vancomycin-Resistant Enterococcus Concomitant With Administration of a Microbiota-Based Drug Targeted at Recurrent Clostridium difficile InfectionOpen Forum Infectious Diseases, 2016
- The human microbiota: novel targets for hospital-acquired infections and antibiotic resistanceAnnals of Epidemiology, 2016
- Fecal Microbiota Transplantation for Clostridium difficile InfectionAnnals of Internal Medicine, 2015
- Burden ofClostridium difficileInfection in the United StatesNew England Journal of Medicine, 2015
- Microbiota-mediated colonization resistance against intestinal pathogensNature Reviews Immunology, 2013
- Intestinal colonization resistanceImmunology, 2012
- The growing incidence and severity ofClostridium difficileinfection in inpatient and outpatient settingsExpert Review of Gastroenterology & Hepatology, 2010
- Epidemiology of urinary tract infections: Incidence, morbidity, and economic costsDisease-a-Month, 2003